Status:

TERMINATED

Chordate System S020 Acute Migraine Clinical Investigation

Lead Sponsor:

Chordate Medical

Conditions:

Acute Migraine

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

The main purpose of the study is to evaluate the impact of treatment with the Chordate System S020 (medical device) on acute migraine headache pain.

Detailed Description

One single migraine attack will be treated either with the Chordate System S020 or with Chordate System in placebo mode. After a screening visit, up to 3 months before treatment, eligible subjects wi...

Eligibility Criteria

Inclusion

  • Subjects with migraine, with or without aura according to International Headache Society (IHS) classification (International Classification of Headache Disorders \[ICHD\]-III beta).
  • History of 1 to 6 migraine attacks per month for at least 12 previous months.
  • At least 50% of previous migraine attacks had moderate or severe pain intensity.
  • History of at least 48 hours of freedom from headache between migraine attacks.
  • The majority of the previous untreated migraine attacks lasted at least 8 hours.
  • Migraine onset before the age of 50 years.

Exclusion

  • History (within one year prior to inclusion into this clinical investigation) of 15 or more headache days per month (i.e. headaches of any kind).
  • More than 6 days per month with non-migraine headaches (within one year prior to inclusion into this clinical investigation).
  • Unable to distinguish between migraine headaches and other headache types at the onset of a migraine attack.
  • Treatment with Botox in the head/neck area within 6 months of the screening visit, or between the screening and treatment visit.
  • Previously treated with an implantable stimulator or any implantable devices in the head and/or neck.
  • Pronounced anterior septal nasal deviation.

Key Trial Info

Start Date :

July 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2015

Estimated Enrollment :

51 Patients enrolled

Trial Details

Trial ID

NCT02185703

Start Date

July 1 2014

End Date

July 1 2015

Last Update

August 5 2015

Active Locations (9)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (9 locations)

1

Universitätsklinikum Tübingen / Zentrum für Neurologie

Tübingen, Baden-Wurttemberg, Germany, 72076

2

Praxis für Neurologie und Psychiatrie, Psychotherapie, Schmerztherapie

Erding, Bavaria, Germany, 85435

3

Neurologie- & Kopfschmerzzentrum

München, Bavaria, Germany, 80802

4

Klinikum Großhadern / Neurologische Klinik der Universität München

München, Bavaria, Germany, 81377